The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
PMV Pharmaceuticals, Inc
PMV Pharmaceuticals, Inc
AstraZeneca
Arvinas Inc.
University of Nebraska
Seagen Inc.
City of Hope Medical Center
University of Southern California
Elicio Therapeutics
TransThera Sciences (Nanjing), Inc.
Instituto do Cancer do Estado de São Paulo
Elevation Oncology
University of California, San Diego
TransThera Sciences (Nanjing), Inc.
MacroGenics
Abramson Cancer Center at Penn Medicine
University of Magdeburg
Swiss Cancer Institute
Memorial Sloan Kettering Cancer Center
OHSU Knight Cancer Institute
Stanford University
National Cancer Institute (NCI)
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Auron Healthcare GmbH
National Cancer Institute (NCI)
Duke University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Massachusetts General Hospital
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
NYU Langone Health
Case Comprehensive Cancer Center